| Literature DB >> 28392148 |
Chihaya Yamada1, Aina Gotoh2, Mikiyasu Sakanaka3, Mitchell Hattie4, Keith A Stubbs4, Ayako Katayama-Ikegami3, Junko Hirose5, Shin Kurihara3, Takatoshi Arakawa6, Motomitsu Kitaoka7, Shujiro Okuda8, Takane Katayama9, Shinya Fushinobu10.
Abstract
Breast-fed infants generally have a bifidobacteria-rich microbiota with recent studies indicating that human milk oligosaccharides (HMOs) selectively promote bifidobacterial growth. Bifidobacterium bifidum possesses a glycoside hydrolase family 20 lacto-N-biosidase for liberating lacto-N-biose I from lacto-N-tetraose, an abundant HMO unique to human milk, while Bifidobacterium longum subsp. longum has a non-classified enzyme (LnbX). Here, we determined the crystal structure of the catalytic domain of LnbX and provide evidence for creation of a novel glycoside hydrolase family, GH136. The structure, in combination with inhibition and mutation studies, provides insight into the molecular mechanism and broader substrate specificity of this enzyme. Moreover, through genetic studies, we show that lnbX is indispensable for B. longum growth on lacto-N-tetraose and is a key genetic factor for persistence in the gut of breast-fed infants. Overall, this study reveals possible evolutionary routes for the emergence of symbiosis between humans and bifidobacterial species in the infant gut.Entities:
Keywords: X-ray crystallography; bifidobacteria; glycoside hydrolase; human microbe co-evolution; human microbe symbiosis; human milk oligosaccharides; infant gut microbiota; inhibitors; lacto-N-biosidase; lacto-N-tetraose
Mesh:
Substances:
Year: 2017 PMID: 28392148 DOI: 10.1016/j.chembiol.2017.03.012
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116